1
Clinical Trials associated with Anti-CD19 CAR T-cells(KK Women's and Children's Hospital)CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol
The purpose of this study is to describe feasibility of delivering point-of-care manufactured CD19-directed CAR T-cell therapy to patients with relapsed/ refractory B-lineage leukaemia/ lymphoma.
100 Clinical Results associated with Anti-CD19 CAR T-cells(KK Women's and Children's Hospital)
100 Translational Medicine associated with Anti-CD19 CAR T-cells(KK Women's and Children's Hospital)
100 Patents (Medical) associated with Anti-CD19 CAR T-cells(KK Women's and Children's Hospital)
100 Deals associated with Anti-CD19 CAR T-cells(KK Women's and Children's Hospital)